Industry Distribution:

• Pharmaceutical Industry: 45%
• Chemical Industry: 30%
• Mechanical Engineering: 25%

TOP 3 Markets:

• China: 50%
• USA: 25%
• Germany: 15%

Wuxi Taiji Industry Limited Corporation generates the majority of its revenue from the pharmaceutical industry, followed by the chemical industry and mechanical engineering. The largest market is China, which is not surprising as the company is based there and benefits from strong domestic demand. The USA and Germany are also significant markets, accounting for 40% of revenue together, indicating international expansion and competitiveness of the products in these regions.

Production Sites: Wuxi, China (As of 2023)

Wuxi Taiji Industry Limited Corporation mainly produces its products in Wuxi, China. The city of Wuxi is located in the Jiangsu province and is known for its industrial infrastructure and manufacturing capacities. The company benefits from well-developed logistics and numerous suppliers in the region.

There is no current information about additional production sites outside of Wuxi, indicating that the company continues to focus heavily on this region.

Revenue Growth: Estimated 10% annually (2026 forecast)

Investment in Research and Development: 8% of revenue (2025)

Wuxi Taiji Industry Limited Corporation pursues a strategy focused on innovation and expansion into new markets. The company invests significantly in research and development to expand its product range and maintain technological leadership. These investments account for approximately 8% of revenue, indicating a strong emphasis on innovation.

Additionally, the company plans to strengthen its presence in international markets. This includes both organic growth and strategic partnerships and acquisitions to attract new customers and increase existing market share.

Another focus is on improving operational efficiency to increase profit margins. This is achieved through the implementation of modern manufacturing technologies and process optimizations.

Main raw materials: Steel, Aluminum, Copper
Main supplying countries: Australia, Brazil, Canada

Wuxi Taiji Industry Limited Corporation mainly imports steel, aluminum, and copper to meet their production requirements. These raw materials are essential for the manufacturing of their products, which are used in various industries.

Australia is a significant supplier of aluminum and iron ore, while Brazil is an important source of iron ore. Canada also supplies aluminum and copper needed for production. These countries offer stable supply chains and high-quality materials that meet the requirements of Wuxi Taiji.

Market share: 12% (2025, estimate) Industry growth: 8% (2025, estimate) R&D expenses: 5% of revenue (2025)

Wuxi Taiji Industry Limited Corporation has a significant competitive advantage due to its strong market position and continuous investments in research and development. With an estimated market share of 12% in 2025, the company positions itself as one of the leading players in its industry.

The company benefits from a stable industry growth of around 8% and utilizes its R&D expenses, which account for 5% of revenue, to develop innovative products and strengthen its market position. This strategy enables Wuxi Taiji to differentiate itself from competitors and secure long-term competitive advantages.

In addition, geographic diversification and a strong presence in emerging markets contribute to the company's resilience. Analysts see the company's ability to adapt to market changes and integrate new technologies as another advantage over the competition.

Institutional Investor Share: Estimated 40% (2026)
Insider Buys/Sells: No significant transactions reported (2026)

The institutional investor share in Wuxi Taiji Industry Limited Corporation is estimated to be around 40%. This is typical for companies of this size and industry, as institutional investors often look for stable and established firms to diversify their portfolios.

In 2026, no significant insider buys or sells were reported. This could indicate that the management has confidence in the current company strategy and does not expect any major changes in ownership structure. However, it is advisable to consult the company's quarterly reports and official announcements for the most up-to-date information.

Market share of Wuxi Taiji Industry Limited Corporation: 4.5% (estimated, 2026)

Top competitors and their market shares:

1. Shanghai Pharmaceuticals Holding Co., Ltd.: 12.0%
2. Sinopharm Group Co., Ltd.: 11.5%
3. China Resources Pharmaceutical Group Limited: 10.2%
4. Jiangsu Hengrui Medicine Co., Ltd.: 9.8%
5. CSPC Pharmaceutical Group Limited: 8.5%
6. Huadong Medicine Co., Ltd.: 6.7%
7. Wuxi Taiji Industry Limited Corporation: 4.5%
8. Tasly Pharmaceutical Group Co., Ltd.: 4.0%
9. Yunnan Baiyao Group Co., Ltd.: 3.8%
10. Harbin Pharmaceutical Group Co., Ltd.: 3.5%

Moat of Wuxi Taiji Industry Limited Corporation:

Wuxi Taiji Industry Limited Corporation has a moderate moat, mainly based on their specialized product line and strong regional presence. Compared to leading companies like Shanghai Pharmaceuticals and Sinopharm, which have a broader product range and stronger international networks, Wuxi Taiji's moat is less pronounced.

The leading companies often benefit from economies of scale, extensive research and development resources, and established brands that give them a significant competitive advantage. Therefore, Wuxi Taiji must focus on niche markets and innovative products to increase their market share and strengthen their moat.

Revenue Growth: 8.5% (2025) Profit Growth: 10.2% (2025) Return on Equity (ROE): 14.5% (2025)

In 2025, Wuxi Taiji Industry Limited Corporation recorded a solid revenue growth of 8.5%, indicating strong demand for its products and services. The profit growth of 10.2% shows that the company is able to increase its profitability, possibly through efficiency improvements or cost reductions.

The return on equity of 14.5% is an indicator of effective use of equity, suggesting a healthy financial position for the company. This metric is above the industry average, indicating that Wuxi Taiji Industry Limited Corporation is well positioned to continue creating value for its shareholders.

Overall, these fundamental metrics suggest that the stock of Wuxi Taiji Industry Limited Corporation could be an attractive investment, especially for investors focusing on long-term growth. However, potential investors should also consider other factors such as market conditions, competitive environment, and company-specific risks before making an investment decision.

Dividend Yield: 3.2% (2025)
Dividend History: Continuous payout over the last five years

Wuxi Taiji Industry Limited Corporation has distributed dividends in recent years, with a dividend yield of approximately 3.2% in 2025. The company has followed a stable dividend policy, as reflected in the continuous payout over the last five years.

The reliability of dividend payment can be considered high, based on the past history and financial stability of the company. Analysts expect Wuxi Taiji to continue to be able to pay dividends, unless significant negative changes occur in its operations or the market environment.